High-end Medical Device Technical Services
HydroLAST
Hydrophilic Surface Treatment
High-quality Coating Technical Services
Effectively improve the hydrophilic lubrication properties of material surfaces
Exclusive Technical License from U.S. AST Products, Inc.
| 「HydroLAST」 Proprietary hydrophilic surface treatment technology is licensed from U.S. AST Products, Inc. It’s ideal for clients without immediate in-house production capabilities. Comprehensive coating services ensure high-quality coated medical devices deliver consistent and superior performance.The entire coating service process is conducted in our Class 10,000 cleanrooms and strictly adheres to the requirements of the ISO 13485 Quality Management System.
|
Principle of operation
This is a treatment process where hydrophilic polymers are firmly coated onto the surface of hydrophobic substrates. These hydrophilic polymers possess functional groups such as carboxyl, hydroxyl or amino groups, which can loosely bind water molecules. After this treatment, the substrate surface becomes easily wettable, allowing water or reagents to flow smoothly over it. Unlike traditional hydrophilic treatment methods, HydroLAST can impart durable hydrophilicity to the material, rather than a temporary effect.
Cutting-Edge Technical Support 
AST Products, Inc., a subsidiary of the Group, boasts a portfolio of proprietary hydrophilic lubrication coating formulations and advanced curing technologies. The lubricity, adhesion strength and thickness of the coatings are all adjustable. Beyond its application to common plastic tubing, the coating can be widely utilized on various hard-to-coat materials.
Easy Client Registration 
AST Products, Inc.'s hydrophilic lubrication coating has a long-standing and extensive customer usage base. The coating holds a filing number with the FDA, and meanwhile, products incorporating the coating used by customers have an extensive registration base with drug regulatory authorities in the United States, the European Union, China and numerous other countries and regions.
|
LubriMATRIX
Lubricious Hydrophilic Coating
Surpass existing surface lubrication treatment technologies
Marks a brand-new milestone for IOL Delivery Device
Exclusive Technical License from U.S. AST Products, Inc.
Marks a brand-new milestone for IOL Delivery Device
Exclusive Technical License from U.S. AST Products, Inc.
| 「LubriMATRIX」
A surface hydrophilic surface treatment technology, independently developed and patented licensed from U.S. AST Products, Inc. This technology can lubricate the surfaces of medical devices across diverse clinical fields, adsorb and retain moisture, significantly reduce the surface friction resistance of medical devices, prevent severe abrasion between device surfaces and tissues/vessel walls, and enable the devices to deliver their optimal performance.
|
Principle of operation
Dynamic hydrogen bonding exists between the coating polymer matrix and the surrounding water molecules. Biocompatible hydrophilic polymers and the support network are entangled with each other,forming a hydrogel-like structure. When the hydrophilic coating comes into contact with water or body fluids, its surface exhibits excellent lubricity and hydrophilicity. Furthermore, it still maintains good coating integrity and lubricity even after multiple friction test cycles.
Cutting-Edge Technical Support 
AST Products, Inc., a subsidiary of the Group, boasts a portfolio of proprietary hydrophilic lubrication coating formulations and advanced curing technologies. The lubricity, adhesion strength and thickness of the coatings are all adjustable. Beyond its application to common plastic tubing, the coating can be widely utilized on various hard-to-coat materials.In particular, it holds a leading global position in its application to IOL Delivery Device.
Easy Client Registration 
AST Products, Inc.'s hydrophilic lubrication coating has a long-standing and extensive customer usage base. The coating holds a filing number with the FDA, and meanwhile, products incorporating the coating used by customers have an extensive registration base with drug regulatory authorities in the United States, the European Union, China and numerous other countries and regions.
|
